3% diquafosol ophthalmic solution

diquafosol

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3% diquafosol ophthalmic solution, covering 2022-06-01 to 2022-06-01. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye [Phase 4]